The Global Hematology Analyzer and Reagent Market size are projected to grow from $2.4 billion in 2021 to $3.8 billion by 2028, growing at a CAGR of 5.1% for the period of 2021-2028. The major driver for this growth will be increasing demand for hematology analyzers and reagents in emerging economies such as the Asia Pacific where diagnostic testing is more affordable than Western nations but quality standards are not compromised due to lower costs associated with manufacturing or sourcing materials locally.
Hematology Analyzer and Reagent are the systems which help in analyzing blood cells, including red blood cells (RBCs), white blood cell (WBCs) as well as platelets. A hematologist is a doctor who diagnoses diseases by testing various samples of a patient's blood using these analyzers. Hematology Analyzer and Reagent are broadly classified into two categories-analyzers as well as reagents. Hematology Analyzers comprise equipment, software, and consumable supplies to analyze the blood cells while Reagents include a broad range of items that assist in performing laboratory tests on the samples such as hemoglobinometer test kits.
Hematology Analyzers are used to diagnose and monitor a variety of blood-related conditions, such as anemia, leukemia, sickle-cell disease, clotting disorders, or infectious diseases. They can also be used for hematopoietic stem cell transplantation procedures in which the patient’s bone marrow is removed from their body before being returned after treatment with chemotherapy or radiation therapy.
The major types of Hematology Analyzer devices include centrifugal analyzers that detect hemoglobin levels by spinning samples at high speed; flow cytometers that use fluorescent dyes to identify cells based on their size and shape; immunophenotypers that combine light microscopy with antibodies against specific antigens found on the surface of cells; cytometers that perform cellular analysis by measuring the amount of light transmitted through cells and flow cytometers.
On the basis of Type, the market is segmented into Hematology Analyzers and Hematology Reagents.
The Hematology analyzer is the equipment that performs various tests on blood samples to determine different parameters of the sample such as cell count, hemoglobin level, platelet number among other things. The process uses centrifuges or flows cytometers to separate out cells from whole blood based on their size and density so they can then be analyzed by one or more methods for further analysis which may include immunophenotyping using antibodies against surface markers like CD45, TER119, etc., fluorescence-activated cell sorting (FACS) where fluorochromes are used to label specific targets in cells and light-scatter techniques such as Coulter counter technology.
Hematology Reagents refers to the reagent packages used in hematology analyzers. These are packaged together with an analyzer or sold separately and they contain various solutions, buffers, antibodies, etc. They are used as a diagnostic tool for blood diseases such as leukemia (for eosinophils), sickle cell disease (to identify hemoglobin S), and so on. It is also important to note that these products are regulated by the FDA under their 510(k) clearance process which means that they receive "a substantial equivalence" classification from regulators based on their similarity to products already approved within the USA market.
The major types of Hematology Reagent devices include blood collection tubes, micropipettes for drawing up samples from test tubes or vials, pipette tips to transfer fluids between vessels, microscope slides, and other laboratory equipment such as gloves and protective gowns. The reagents used in these analyzers are designed to bind with a target substance present in the sample under examination so they can be visualized more easily using fluorescent dyes or antibodies recognized by specific markers on their surface.
On the basis of Application, the market is segmented into Hospitals, Blood Bank and Research Institutions. Hematology Analyzer is used in the diagnosis of a variety of hematological conditions such as iron deficiency anemia, thalassemia/thalassemia, and leukemia while it’s available in two types namely analyzers and reagents.
On the basis of Region, the market is segmented into North America, Latin America, Europe, and the Asia Pacific. The U.S., Brazil, Germany, and China are the leading countries in this market with a major share of about 48% in terms of revenue contribution to the global hematology analyzer and reagent market by 2028 end.
In Europe, Germany accounts for the highest market share followed by France & Italy. Western European countries are in high demand due to their aging population and low fertility rates which increases its prevalence rate resulting in higher requirements for hematological testing services. Countries such as Brazil (BRL) have been witnessing strong economic growth over the last decade; this has led to an increase in disposable income levels that provide opportunities for healthcare spending including expenditure on diagnostic equipment used in hematology laboratories or medical centers.
The Asia Pacific market is expected to grow moderately over the forecast period. The growth in this region is attributed to rising awareness about chronic diseases, increasing disposable incomes, and government investments in the healthcare infrastructure sector which will lead to an increase in demand for novel diagnostic technologies that can provide an accurate diagnosis with a less invasive procedure such as blood testing devices.
Up Market Research published a new report titled “Hematology Analyzer and Reagent Market research report which is segmented by Types (Analyzer, Reagent), By Applications (Hospital, Blood Bank, Research Institutions), By Players/Companies Bio-Rad Laboratories, Immucor, Ortho Clinical Diagnostics, Grifols, Haemotec, Hemo bioscience, Institut de Biotechnologies Jacques Boy”.
Report Attributes | Report Details |
Report Title | Hematology Analyzer and Reagent Market Research Report |
By Type | Analyzer, Reagent |
By Application | Hospital, Blood Bank, Research Institutions |
By Companies | Bio-Rad Laboratories, Immucor, Ortho Clinical Diagnostics, Grifols, Haemotec, Hemo bioscience, Institut de Biotechnologies Jacques Boy |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 231 |
Number of Tables & Figures | 162 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Type Analyzer, Reagent and By Application Hospital, Blood Bank, Research Institutions.
Some of the companies that are profiled in this report are:
Hematology Analyzer and Reagent Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Hematology Analyzer and Reagent Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Hematology Analyzer and Reagent Market Report:
Some other reports from this category!